Zhenwei Deng
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Ya Liu (6 shared papers)Xiguang Chen (6 shared papers)Cong-Shan Yuan (3 shared papers)Ting Wang (1 shared paper)Yuxin Tang (5 shared papers)Di Qin (1 shared paper)Yuzhi Mu (1 shared paper)Libo Li (4 shared papers)
In The Last Decade
Zhenwei Deng
19 papers receiving 404 citations
Peers
Comparison fields: 5 of 75
- Biomaterials 84
- Cancer Research 78
- Immunology 50
- Oncology 56
- Biomedical Engineering 98
Countries citing papers authored by Zhenwei Deng
This map shows the geographic impact of Zhenwei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Deng more than expected).
Fields of papers citing papers by Zhenwei Deng
This network shows the impact of papers produced by Zhenwei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Deng. The network helps show where Zhenwei Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenwei Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 60 | |
| 2 | 2021 | 60 | |
| 3 | 2015 | 39 | |
| 4 | 2018 | 35 | |
| 5 | 2022 | 34 | |
| 6 | 2014 | 33 | |
| 7 | 2020 | 33 | |
| 8 | 2015 | 24 | |
| 9 | 2019 | 22 | |
| 10 | 2022 | 21 | |
| 11 | 2018 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2015 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2019 | 1 | |
| 19 | 2024 | 1 |
About Zhenwei Deng
Zhenwei Deng is a scholar working on Cancer Research, Oncology, Immunology, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 19 papers that have together received 407 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Immunotherapy and Immune Responses (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (2 papers), Circular RNAs in diseases (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Biomaterials (84 citations), Cancer Research (78 citations), Immunology (50 citations), Oncology (56 citations) and Biomedical Engineering (98 citations). Zhenwei Deng has collaborated with scholars based in China and Taiwan. Frequent co-authors include Ya Liu, Xiguang Chen, Cong-Shan Yuan, Ting Wang, Yuxin Tang, Di Qin, Yuzhi Mu, Libo Li, Na Wang and Ruiping Li. Their work appears in journals such as Journal of Controlled Release, Biochemical and Biophysical Research Communications, Surgical Endoscopy, Frontiers in Genetics and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.